IRVING, Texas, April 8, 2011 /PRNewswire/ — Novation, the
leading health care supply contracting company, announced today the
addition of St. Jude Medical (St. Paul, MN) to its portfolio of
agreements for Cardiac Rhythm Management products.
St. Jude Medical is a leading provider of medical devices which
treat cardiac, neurological and chronic pain patients. The company
provides a full portfolio of arrhythmia management products,
including pacemakers, implantable cardioverter defibrillators
(ICDs) and leads.
Effective April 1, 2011 the agreement features a complete
product offering, locally-negotiated pricing and market share
growth rebates as well as price protections and transparency
offered through GPO contracts. The new 30-month agreement marks the
first collaboration between Novation and St. Jude Medical.
“We are pleased to partner with Novation and their member
hospitals to provide additional access to St. Jude Medical’s life
sustaining technologies. The new agreement has the potential to
both increase the use of our arrhythmia management therapies and
help to create efficiencies in the supply chain,” said Mike
Rousseau, Group President of St. Jude Medical.
During Novation’s due diligence in this product category, the
members of VHA Inc., the University HealthSystem Consortium (UHC)
and Provista were overwhelmingly supportive of St. Jude Medical and
their products. The products were viewed as both innovative and
relevant to meeting their needs of providing quality care at an
appropriate price.
“We are excited about the new agreement with St. Jude Medical
and how it rounds out our already strong portfolio in this space.
We view their products as being both innovative and relevant to
meeting the needs of our members,” said Pete Allen, senior vice
president, sourcing operations at Novation. “We are looking forward
to St. Jude Medical’s pipeline of new technologies, many which we
expect to soon be available in the United Stat
‘/>”/>
